Back to directory
Country
United States
City
San Diego
Founded
2021
Headcount
51-200
california
Description
Degron Therapeutics is a biotechnology company focused on developing a molecular glue degrader platform.
Funding history
-
Series A 2026-05-14
Degron Therapeutics is a biotechnology company focused on developing a molecular glue degrader platform.
$40,000,000
Source
Founders
-
Siwei Li